Doug Monroe of Kaiser Permanente's 2015 Presentation

Kaiser Permanente: the impact of biosimilars on private reimbursement

We were excited to have Doug Monroe, Project Manager of Biotechnology, Emerging Technology, and Specialty Pharmacy at Kaiser Permanente, share his expertise on the impact of biosimilars on private reimbursement strategies at the World Biosimilar Congress USA.

Download his presentation now >

You can now download Doug’s presentation to find out more about:

  • The Kaiser Permanente integrated health care delivery system
  • Biosimilar: planning in managed care
  • The FDA’s Purple Book
  • Interchangeability
  • Switching
  • P&T issues

Download his presentation now >

The World Biosimilar Congress USA is where biopharma developing biosimilars gather to discuss how to access the US market. This year’s event will take place May 19-20 at the Hilton San Diego Resort and Spa.

Click here to register now >

Leave a Reply

Your email address will not be published. Required fields are marked *